Changjiang Dong
Impact in
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
- Endocrinology top 1%
Papers in
-
- Antibiotic Resistance in Bacteria 14
-
- Escherichia coli research studies 5
- Co-authors
- James H. NaismithHaohao DongWenjian WangChris WhitfieldSilvana FlecksKarl‐Heinz van PéeYinghong GuKonstantinos Beis
- Journals
- Nature (6 papers)Journal of Virology (3 papers)Nature Structural & Molecular Biology (3 papers)Scientific Reports (2 papers)Nature Communications (2 papers)
- Partner nations
- United KingdomChinaUnited States
In The Last Decade
Changjiang Dong
63 papers receiving 4.1k citations
Peers
Comparison fields: 5 of 129
- Molecular Medicine 483
- Endocrinology 309
- Molecular Biology 2.2k
- Genetics 881
- Infectious Diseases 524
Countries citing papers authored by Changjiang Dong
This map shows the geographic impact of Changjiang Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changjiang Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changjiang Dong more than expected).
Fields of papers citing papers by Changjiang Dong
This network shows the impact of papers produced by Changjiang Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changjiang Dong. The network helps show where Changjiang Dong may publish in the future.
Co-authors
The 25 scholars most cited alongside Changjiang Dong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 13 | |
| 2 | 2023 | 38 | |
| 3 | 2022 | 55 | |
| 4 | 2022 | 5 | |
| 5 | 2021 | 47 | |
| 6 | 2020 | 63 | |
| 7 | 2020 | 48 | |
| 8 | 2020 | 29 | |
| 9 | 2017 | 54 | |
| 10 | 2017 | 19 | |
| 11 | 2013 | 35 | |
| 12 | 2013 | 69 | |
| 13 | 2010 | 110 | |
| 14 | 2008 | 164 | |
| 15 | 2007 | 115 | |
| 16 | 2006 | 279 | |
| 17 | 2005 | 320 | |
| 18 | 2004 | 268 | |
| 19 | 2004 | 20 | |
| 20 | 2003 | 34 |
About Changjiang Dong
Changjiang Dong is a scholar working on Molecular Medicine, Endocrinology, Genetics, Infectious Diseases and Molecular Biology, having authored 65 papers that have together received 4.2k indexed citations. Recurring topics across this work include Bacterial Genetics and Biotechnology (20 papers), Antibiotic Resistance in Bacteria (14 papers), Enzyme Structure and Function (7 papers), Drug Transport and Resistance Mechanisms (6 papers), Glycosylation and Glycoproteins Research (5 papers), Ubiquitin and proteasome pathways (5 papers), Escherichia coli research studies (5 papers) and Bacteriophages and microbial interactions (5 papers). The work is most often cited by research in Molecular Medicine (483 citations), Endocrinology (309 citations), Molecular Biology (2.2k citations), Genetics (881 citations) and Infectious Diseases (524 citations). Changjiang Dong has collaborated with scholars based in United Kingdom, China and United States. Frequent co-authors include James H. Naismith, Haohao Dong, Wenjian Wang, Chris Whitfield, Silvana Flecks, Karl‐Heinz van Pée, Yinghong Gu, Konstantinos Beis, Ronald T. Hay and Neil G. Paterson. Their work appears in journals such as Nature, Journal of Virology, Nature Structural & Molecular Biology, Scientific Reports and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.